⌘K

Home/Filings/4/A/0001209191-19-038981

4/A//SEC Filing

Chen Ivan 4/A

Accession 0001209191-19-038981

CIK 0001006028other

View on SEC.gov Company Profile

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 5:21 PM ET

Size

5.0 KB

Accession

0001209191-19-038981

Insider Transaction Report

Form 4/AAmended

Period: 2019-05-09

PURE BIOSCIENCE, INC.PURE

Director

Transactions

Purchase
Common Stock
2019-05-09$0.29/sh+120,689$35,000→ 270,689 total

Footnotes (1)

[F1]The original Form 4 Report filed May 13, 2019 stated that the number of shares acquired was 100,000 at a price of $0.35 per share. This amendment reflects an amendment to the price per share.

Documents

1 file

4
doc4a.xml
FORM 4/A SUBMISSION

Issuer

PURE BIOSCIENCE, INC.

CIK 0001006028

Entity typeother

Related Parties

1

filerCIK 0001743729

Filing Metadata

Form type: 4/A
Filed: Jun 24, 8:00 PM ET
Accepted: Jun 25, 5:21 PM ET
Size: 5.0 KB

View on SEC.gov